HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoling Li Selected Research

Chemokine CCL19

1/2020Targeted MIP-3β plasmid nanoparticles induce dendritic cell maturation and inhibit M2 macrophage polarisation to suppress cancer growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoling Li Research Topics

Disease

187Neoplasms (Cancer)
07/2022 - 07/2003
52Nasopharyngeal Carcinoma
01/2022 - 09/2003
37Neoplasm Metastasis (Metastasis)
01/2022 - 03/2007
35Inflammation (Inflammations)
06/2022 - 11/2008
34Carcinogenesis
01/2021 - 07/2005
29Burns
01/2022 - 05/2005
19Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 08/2004
13Infections
01/2022 - 02/2009
13Breast Neoplasms (Breast Cancer)
01/2022 - 01/2007
11Ischemia
08/2022 - 01/2002
11Obesity
01/2022 - 04/2009
11Glioma (Gliomas)
01/2018 - 08/2006
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 01/2012
8Mitochondrial Diseases (Mitochondrial Disease)
02/2022 - 01/2011
8Lung Neoplasms (Lung Cancer)
11/2021 - 10/2013
8Hypoxia (Hypoxemia)
01/2021 - 01/2002
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2022 - 01/2021
7Insulin Resistance
09/2022 - 09/2010
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2003
7Type 2 Diabetes Mellitus (MODY)
03/2020 - 12/2013
7Melanoma (Melanoma, Malignant)
01/2019 - 12/2009
7Glioblastoma (Glioblastoma Multiforme)
09/2018 - 11/2006
7Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2012
6Disease Progression
10/2022 - 01/2021
6Fibrosis (Cirrhosis)
01/2022 - 04/2012
6Wounds and Injuries (Trauma)
01/2022 - 11/2015
6COVID-19
12/2021 - 01/2020
5Colitis
12/2022 - 01/2017
5Fatigue
10/2022 - 11/2009
5Metabolic Diseases (Metabolic Disease)
01/2022 - 04/2009
5Epstein-Barr Virus Infections
01/2022 - 01/2012
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 05/2003
5Genomic Instability
11/2021 - 02/2012
5Atherosclerosis
08/2021 - 10/2007
5Adenocarcinoma of Lung
05/2021 - 10/2013
5Colonic Neoplasms (Colon Cancer)
02/2019 - 01/2016
5Edema (Dropsy)
07/2011 - 05/2005
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022 - 09/2016
4Hypertension (High Blood Pressure)
10/2022 - 11/2021
4Necrosis
10/2021 - 03/2016
4Body Weight (Weight, Body)
01/2021 - 05/2008
4Carcinoma (Carcinomatosis)
01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

74Proteins (Proteins, Gene)FDA Link
04/2022 - 02/2002
35Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2008
32Long Noncoding RNAIBA
08/2022 - 01/2014
26Pharmaceutical PreparationsIBA
01/2022 - 01/2007
24MicroRNAs (MicroRNA)IBA
10/2021 - 04/2010
21salicylhydroxamic acid (SHAM)IBA
01/2022 - 05/2004
20Sirtuin 1IBA
04/2022 - 10/2007
19RNA (Ribonucleic Acid)IBA
01/2022 - 03/2007
17Ethanol (Ethyl Alcohol)IBA
01/2022 - 08/2009
17Messenger RNA (mRNA)IBA
10/2021 - 11/2008
16CytokinesIBA
01/2022 - 08/2006
15Biological ProductsIBA
01/2022 - 11/2013
12DNA (Deoxyribonucleic Acid)IBA
11/2021 - 08/2004
11Interleukin-18 (Interleukin 18)IBA
05/2021 - 05/2005
10Therapeutic UsesIBA
09/2022 - 03/2010
10Glucose (Dextrose)FDA LinkGeneric
09/2022 - 07/2010
10Circular RNAIBA
01/2022 - 01/2017
9Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 06/2002
9LipidsIBA
01/2022 - 06/2002
9SeleniumIBA
01/2021 - 01/2012
9EnzymesIBA
01/2020 - 06/2002
8Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 12/2015
8LigandsIBA
01/2022 - 06/2004
7Insulin (Novolin)FDA Link
09/2022 - 02/2012
7NAD (NADH)IBA
01/2022 - 02/2012
7VaccinesIBA
01/2022 - 06/2014
7Complementary DNA (cDNA)IBA
08/2015 - 09/2003
6CholesterolIBA
09/2022 - 07/2010
6Oxygen (Dioxygen)IBA
06/2022 - 07/2010
6Interleukin-6 (Interleukin 6)IBA
06/2022 - 07/2011
6Interleukin-22 (IL-22)IBA
01/2022 - 01/2013
6IronIBA
01/2022 - 09/2018
6AntioxidantsIBA
01/2021 - 03/2015
6Peroxidase (Myeloperoxidase)IBA
01/2020 - 05/2005
6Peptides (Polypeptides)IBA
01/2020 - 09/2014
6Small Interfering RNA (siRNA)IBA
01/2020 - 12/2008
6Paclitaxel (Taxol)FDA LinkGeneric
03/2019 - 12/2012
5anlotinibIBA
10/2022 - 01/2021
5PolymersIBA
04/2022 - 08/2014
5Interleukin-2 (IL2)IBA
01/2022 - 07/2005
5HydrogelsIBA
01/2022 - 01/2015
5Caspase 3 (Caspase-3)IBA
06/2021 - 05/2008
5Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 03/2008
5Antiviral Agents (Antivirals)IBA
01/2020 - 11/2016
5LactoferrinIBA
02/2015 - 11/2008
5Leucine (L-Leucine)FDA Link
12/2009 - 08/2006
4Immune Checkpoint InhibitorsIBA
07/2022 - 01/2019
4Competitive Endogenous RNAIBA
01/2022 - 12/2013
4RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 12/2017
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2010
4Phosphotransferases (Kinase)IBA
01/2022 - 04/2010
4Untranslated RNA (Noncoding RNA)IBA
01/2021 - 10/2013
4ezrinIBA
01/2021 - 03/2007
4Saline SolutionIBA
01/2021 - 01/2007

Therapy/Procedure

67Therapeutics
12/2022 - 12/2006
18Drug Therapy (Chemotherapy)
10/2022 - 08/2004
15Immunotherapy
01/2022 - 01/2019
10Radiotherapy
11/2021 - 03/2017